Content area
Full text
Under President Trumps leadership, the Centers for Medicare & Medicaid Services (CMS) announced the Part D Senior Savings Model, a voluntary model that enables participating Part D enhanced plans to lower Medicare beneficiaries out-of-pocket costs for insulin to a maximum $35 copay per thirty-day supply throughout the benefit year. Beneficiaries who take insulin and enroll in a plan participating in the model should save an average of $446 in annual out-of-pocket costs for insulin, or over 66 percent, relative to their average cost-sharing for insulin today.
The Models initial projections assume it generates over $250 million in savings over five years for the federal government, largely due to pharmaceutical manufacturers paying additional coverage gap discounts. As beneficiaries have more consistent, predictable access to the prescription drugs they need, the model projects that health will improve and total cost of care will decline for our nations seniors. This Model follows on the Trump Administrations previously announced 13.5 percent decline in the average monthly basic Part D premium since 2017 to the lowest level in 7 years.
A beneficiarys out-of-pocket costs for insulin in Medicares Part D prescription drug benefit can fluctuate from one month to the...